SYNGENE stock
SYNGENE is in a mixed news setup around Pharmaceuticals; 2 recent stories are active but the saved quote move at +0.00% keeps the read balanced.
SYNGENE has built a mixed coverage cluster in the last 11 days. The strongest recurring theme is Pharmaceuticals, while the current weighted impact score is -7 from 1 bullish, 1 bearish, and 0 neutral stories across 1 sources.
SYNGENE is last saved at ₹374 with a day move of +0.00%. That quote should be read with the article tape: a positive headline only matters if price, volume, and follow-through confirm it; a negative headline matters more when it keeps repeating across multiple publishers.
This is the latest financial report for Syngene. The company made ₹943.7 crore in sales and ₹131.1 crore in profit. This information is on record for your review. This hub keeps the permanent stock view separate from short-lived article pages, so search engines and users get one accumulated view instead of scattered programmatic summaries.
Economic Times · 27 days ago · 2 min read
Economic Times · 11 Sept 2026 · 2 min read
Mint · 4 Aug 2026 · 2 min read
Economic Times · 25 Jul 2026 · 2 min read
Economic Times · 3 Jul 2026 · 2 min read
How SYNGENE stacks against related names in this news cluster
SYNGENE has appeared across 2 recent stories from 1 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.
SYNGENE coverage is currently mixed, with 1 bullish, 1 bearish, and 0 neutral analyzed stories in the recent window.
Recent SYNGENE coverage is clustering around Pharmaceuticals and Biotechnology. Related names showing up alongside SYNGENE include EMAMILTD, KPITTECH, RVNL.
Use this page as a coverage hub for SYNGENE: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.
2 recent mentions linked to SYNGENE
TopicBiotechnology1 recent mentions linked to SYNGENE
StockEMAMILTDRelated news cluster with 1 links
Latest storyBullish read: Syngene International & Nifty 500 Stocks Break VWAPThe broader Indian market, as indicated by Gift Nifty and Asian market signals, is showing a positiv
How retail crowds and channels are talking about SYNGENE right now — context for your own research, not a trade call.